Abstract 7326: TP53 p.Pro47Ser polymorphism in breast cancer susceptibility in Mali

Abstract Background: The aim of this study was to assess the potential association of p. Pro47Ser polymorphisms of TP53 with the risk of developing breast cancer in the Malian population. Methods: We analyzed DNA samples from 72 breast cancer patients and 121 unrelated healthy, age-matched individuals to examine the presence of the polymorphisms. The genotyping of TP53 polymorphism was performed using PCR-RFLP and HRM (high-resolution melting) methods. Results: The genotypic frequencies of PP, PS, and SS were found to be 63. 9% PP, 30. 6% PS, and 5. 6% SS in breast cancer patients, compared to 70. 2% PP, 22. 3% PS, and 7. 4% SS in the control group. The frequencies of P and S alleles of TP53 p. P47S polymorphism were 79. 2% vs 81. 4%, 20. 8% vs 18. 6%, and 5% vs 4. 5% in patients and controls, respectively. In this study, no significant correlation was observed between TP53 p. Pro47Ser polymorphism and breast cancer in the Malian population (Pro/Ser vs Pro/Pro: OR = 1. 55, 95% CI = 0. 80-3. 05, P = 0. 19; Ser/Ser vs Pro/Pro: OR = 1. 27, 95% CI = 0. 34-4. 74, P = 0. 71; and Ser vs Pro allele: OR = 1. 39, 95% CI = 0. 80-2. 32, P = 0. 24). Conclusion: Despite the absence of a genetic association between TP53 p. Pro47Ser and the risk of breast cancer in Malian patients, our findings suggest that individuals carrying at least one minor Ser allele are not protected against the disease. Citation Format: Brehima Diakite, Yaya Kassogue, Mamoudou Maiga, Oumar Kassogue, Kadidiatou Cisse, Fousseyni Diarra, Cheick Traore B. Traore, Bakarou Kamate, Jane L. Holl, Lifang Hou. TP53 p. Pro47Ser polymorphism in breast cancer susceptibility in Mali abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Abstract nr 7326.